Five* Latin American nations are set to hold presidential elections in 2021, with some important legislative elections taking place as well. Some of these contests will have implications for cannabis policy, and we will be looking at what is at stake in each vote, starting with Ecuador, which heads to the polls next Sunday, February
On Thursday, January 28, we will be hosting a FREE hour-long webinar discussing the business side of medical and recreational cannabis in Mexico. REGISTER TODAY! In our last post, we alerted you on the publication of the new Regulations on Sanitary Control for the Production, Research and Medical Use of Cannabis and Its Pharmacological Derivatives (the “Medical Regulations”). In
MAG Hemp Regulations In October, Ecuador’s agriculture ministry (MAG) released hemp regulations, in the form of Acuerdo Ministerial No. 109 (English). This follows the National Assembly’s 2019 decriminalization of cannabis with a THC content of less than 1.0% THC (which entered into forced on June 21, 2020). The regulations distinguish between industrial hemp (cáñamo para
According to the UK government, “the BVI [British Virgin Islands] is a separate legal jurisdiction to the United Kingdom and has its own laws.” This being the case, one would think that a medical cannabis bill passed unanimously by the BVI’s legislature would have no problem becoming law. However, the territory’s governor—a British civil servant
On Thursday, January 28, we will be hosting a FREE hour-long webinar discussing the business side of medical and recreational cannabis in Mexico. REGISTER TODAY! As I recently reported on this blog, last November the Mexican Senate approved an amended Cannabis Law bill. That bill was sent to the Lower Chamber for discussion and approval. The Lower Chamber duly
Translations for this blog post can be found below: Chinese/中文 French/ Français German/ Deutsche Spanish/ Español I work with international cannabis companies outside the U.S. and regularly field inquiries from others who want to enter the U.S. market or are already selling into the U.S. market through an intermediary like a broker or a sales
Last week, the European Commission (the “Commission”) retracted its preliminary position on treating hemp-derived cannabidiol (“CBD”) and other extracts derived from the flowering tops of the Cannabis sativa L. plant as narcotics under the U.N. Single Convention on Narcotic Drugs of 1961 (the “Single Convention”). We were relieved to see this development; faithful readers of
A few months ago, I wrote a post entitled, “Israel: Cannabis Powerhouse“. That post noted how Israel has been at the forefront of cannabis for decades. Namely, it was one of the pioneers of cannabis research, an early adopter of medical cannabis, and one of the few countries that has embraced of medical cannabis
The United Nations Commission for Narcotic Drugs (CND) voted on Wednesday to accept the World Health Organization’s (WHO) recommendation to remove cannabis and cannabis resin for medicinal purposes from Schedule IV of the 1961 Single Convention on Narcotic Drugs. It was a close vote – passing 27 to 25, with the United States and notable
An appeals court in Brazil is set to consider the issue of cannabis-related trademarks, and in particular their registrability under the country’s Intellectual Property Law (LPI), which forbids the registration of marks “contrary to morals and good customs” (Article 124, III). One of the key issues at the intersection of cannabis law and cannabis business
